EOM Pharmaceuticals Holdings, Inc. (IMUC)
Sector: Biotechnology
Industry: Biotechnology
EOM Pharmaceuticals Holdings, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 0.0700 | 0.1575 | 0.0700 | 0.1575 | 5,601 |
| Nov 9, 2026 | 0.0521 | 0.1578 | 0.0521 | 0.1578 | 2,780 |
| Nov 3, 2026 | 0.0512 | 0.0524 | 0.0512 | 0.0521 | 9,649 |
| Nov 2, 2026 | 0.0694 | 0.0694 | 0.0694 | 0.0694 | 219 |
| Oct 30, 2026 | 0.0726 | 0.0726 | 0.0726 | 0.0726 | 240 |
| Oct 27, 2026 | 0.0750 | 0.0750 | 0.0750 | 0.0750 | 2,500 |
| Oct 23, 2026 | 0.0441 | 0.1600 | 0.0441 | 0.1580 | 1,793 |
| Oct 21, 2026 | 0.0950 | 0.1208 | 0.0950 | 0.1208 | 2,115 |
| Oct 14, 2026 | 0.0950 | 0.0950 | 0.0950 | 0.0950 | 925 |
| Oct 8, 2026 | 0.0950 | 0.0950 | 0.0950 | 0.0950 | 180 |
| Oct 6, 2026 | 0.1580 | 0.1684 | 0.0950 | 0.1684 | 2,283 |
| Oct 5, 2026 | 0.1050 | 0.1139 | 0.1050 | 0.1139 | 710 |
EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medications. These treatments hold the potential to revolutionize existing therapeutic approaches. Among its key drug candidates currently undergoing development are EOM613 and EOM147. Established on March 20, 1987, the company maintains its corporate headquarters in Montvale, New Jersey.
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
30d Avg
3.11K
60d Avg
5.41K
90d Avg
3.29K
EOM Pharmaceuticals Holdings, Inc. (OTC: IMUC) traded at $0.1575 on Nov 13, 2026, down 0.19% from the previous close of $0.1578. 52-week range: $0.0441 to $0.2700. The company is in the Healthcare sector (Biotechnology).